Showing results 1 to 20 of 30
next >
| Issue Date | Title | Author(s) |
| 2014 | Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich Ataxia | Virmouni, SA; Sandi, C; Al-Mahdawi, S; Pook, MA |
| 19-May-2022 | A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models | Abeti, R; Jasoliya, M; Al-Mahdawi, S; Pook, M; Gonzalez-Robles, C; Hui, CK; Cortopassi, G; Giunti, P |
| 8-Jan-2018 | Effect of diazoxide on Friedreich ataxia models | Santoro, A; Virmouni, SA; Paradies, E; Coa, VLV; Al-Mahdawi, S; Khoo, M; Porcelli, V; Vozza, A; Perrone, M; Denora, N; Taroni, F; Merla, G; Palmieri, L; Pook, MA; Marobbio, CMT |
| 14-Nov-2019 | Elucidation of the metabolic signature of Friedreich’s ataxia | Anjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Perry, N; Tripp, A; Agliano, A; Al-Mahdawi, S; Pook, M |
| 2014 | The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases | Al-Mahdawi, S; Virmouni, SA; Pook, MA |
| 2014 | Epigenetic-based therapies for Friedreich ataxia | Sandi, C; Sandi, M; Virmouni, SA; Al-Mahdawi, S; Pook, MA |
| 2013 | Epigenetics in Friedreich's ataxia: Challenges and opportunities for therapy | Sandi, C; Al-Mahdawi, S; Pook, MA |
| 21-Nov-2018 | FAST-1 antisense RNA epigenetically alters FXN expression | Pook, M; Mikaeili, H; Sandi, M; Bayot, A; Al-Mahdawi, S |
| 2007 | The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues | Pook, MA; Al-Mahdawi, S; Mouro Pinto, R; Sandi, C; Trabzuni, D |
| 2013 | Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus | Al-Mahdawi, S; Sandi, C; Mouro Pinto, R; Pook, MA |
| 2006 | GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology | Pook, MA; Al-Mahdawi, S; Mouro Pinto, R |
| 2006 | The GAA triplet-repeat is unstable in the context of the human FXN locus and displays age-dependent expansions in cerebellum and DRG in a transgenic mouse model | Pook, MA; Clark, RM; De Biase, I; Al-Mahdawi, S; Malykhina, AP; Bidichandani, S |
| 2014 | Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models | Sandi, C; Sandi, M; Jassal, H; Ezzatizadeh, V; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA |
| 14-Nov-2019 | Genotype and Phenotype Characterisation of an Enhanced Friedreich Ataxia GAA Repeat Expansion Mouse Model Fxn_null::YG8s(GAA)>800 | Anjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Kleine, P; Oggianu, C; Hannana, T; Al-Mahdawi, S; Pook, M |
| 2015 | Genotype and phenotype characterisation of enhanced Friedreich’s ataxia GAA repeat expansion mouse models | Anjomani Virmouni, S; Sandi, C; Ezzatizadeh, V; Sandi, M; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S |
| 2013 | Genotype and phenotype characterisation of Friedreich ataxia mouse models and cells | Anjomani Virmouni, Sara |
| 5-Jun-2020 | HMTase Inhibitors as a Potential Epigenetic-based Therapeutic Approach for Friedreich’s Ataxia | Sherzai, M; Valle, A; Perry, N; Kalef-Ezra, E; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S |
| 1-May-2015 | Identification of telomere dysfunction in Friedreich ataxia | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Slijepcevic, P; Pook, M |
| 10-Jun-2015 | Identification of telomere dysfunction in Friedreich ataxia. | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Giunti, P; Slijepcevic, P; Pook, M |
| 2012 | Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model | Tomassini, B; Arcuri, G; Fortuni, S; Sandi, C; Ezzatizadeh, V; Casali, C; Condò, I; Malisan, F; Al-Mahdawi, S; Pook, M; Testi, R |
